Catalyst Wire Dossier Catalyst Wire Dossier

Multiprofen-CC

· KAZM Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Multiprofen-CC, covering 2025-12-10 to 2026-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty [Phase 3]

See pricing